ANGLE PLC (LON:AGL)

ANGLE PLC (LON:AGL)


Share Price
52.50 p
Change
0 (0.00 %)
Market Cap
£75.33 m
Proactive Investors - Run By Investors For Investors

ANGLE PLC

ANGLE PLC develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease.

EPIC: AGL
Market: AIM:AGL
52-week High/Low: 76.00p / 38.00p
Sector: Pharma & Biotech
Market Cap: £75.33 m
Website: www.angleplc.com
col 3
col 4
col 5
col 6

ANGLE PLC RNS Announcements

Date Epic Announcement
11/03/2019 AGL Holding(s) in Company
07/03/2019 AGL ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
28/02/2019 AGL FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
25/02/2019 AGL CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX
11/02/2019 AGL Research into role of immune cells in cancer
31/01/2019 AGL Interim Results
29/01/2019 AGL NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS
11/01/2019 AGL Second Price Monitoring Extn
11/01/2019 AGL Price Monitoring Extension
11/01/2019 AGL Second Price Monitoring Extn
11/01/2019 AGL Price Monitoring Extension
11/01/2019 AGL Second Price Monitoring Extn
11/01/2019 AGL Price Monitoring Extension
10/01/2019 AGL Second Price Monitoring Extn
10/01/2019 AGL Price Monitoring Extension
10/01/2019 AGL BREAKTHROUGH CANCER RESEARCH USING PARSORTIX
09/01/2019 AGL Notice of Results
21/12/2018 AGL Issue of LTIP Options and Share Options
28/11/2018 AGL LEADING US HEMATOPATHOLOGIST APPOINTED AS ADVISOR
13/11/2018 AGL Holding(s) in Company
05/11/2018 AGL Acquisition of outstanding shares
02/11/2018 AGL Price Monitoring Extension
01/11/2018 AGL Appointment of Dr Jan Groen as NED
30/10/2018 AGL Result of AGM
29/10/2018 AGL PARSORTIX SHOWS CAPABILITY TO HARVEST FETAL CELLS
25/10/2018 AGL Good Progress with FDA Studies
09/10/2018 AGL Notice of AGM
28/08/2018 AGL Parsortix shows evidence of CTCs in glioblastoma
25/07/2018 AGL Preliminary Results for year ended 30 April 2018
24/07/2018 AGL EIS/VCT Advance Assurance and Total Voting Rights

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use